China Medical & HealthCare Group Limited
COLRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.54 | 0.39 | -0.62 |
| FCF Yield | -10,302.19% | 24.34% | -24.37% | 2.87% |
| EV / EBITDA | -0.26 | 3.19 | 18.65 | 49.82 |
| Quality | ||||
| ROIC | 2.29% | 1.73% | -1.93% | -1.25% |
| Gross Margin | 19.95% | 18.24% | 11.25% | 11.92% |
| Cash Conversion Ratio | 1.87 | 31.53 | -0.12 | -1.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.19% | 2.04% | 5.81% | 5.71% |
| Free Cash Flow Growth | -154.99% | 228.92% | -288.34% | 156.85% |
| Safety | ||||
| Net Debt / EBITDA | -0.27 | -0.52 | 7.84 | 6.40 |
| Interest Coverage | 2.96 | 1.74 | -0.67 | -0.36 |
| Efficiency | ||||
| Inventory Turnover | 4.52 | 4.18 | 4.09 | 8.83 |
| Cash Conversion Cycle | 68.19 | 42.09 | 67.63 | 20.70 |